Panzara Michael A. 4
4 · Wave Life Sciences Ltd. · Filed Mar 11, 2019
Insider Transaction Report
Form 4
Panzara Michael A.
Franchise Lead, Neurology
Transactions
- Award
Ordinary Shares
2019-03-07+15,000→ 52,388 total - Sale
Ordinary Shares
2019-03-11$48.00/sh−7,000$336,000→ 45,388 total
Footnotes (2)
- [F1]Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2020 through February 15, 2023.
- [F2]Consists of sale of RSUs effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018.